.png){kind=icon}
返回
Personalized tumor combination therapy optimization using the single-cell transcriptome
.png){kind=icon}
OA
AI
DOI：10.1186/s13073-023-01256-6.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
BackgroundThe precise characterization of individual tumors and immune microenvironments using transcriptome sequencing has provided a great opportunity for successful personalized cancer treatment. However, the cancer treatment response is often characterized by in vitro assays or bulk transcriptomes that neglect the heterogeneity of malignant tumors in vivo and the immune microenvironment, motivating the need to use single-cell transcriptomes for personalized cancer treatment.MethodsHere, we present comboSC, a computational proof-of-concept study to explore the feasibility of personalized cancer combination therapy optimization using single-cell transcriptomes. ComboSC provides a workable solution to stratify individual patient samples based on quantitative evaluation of their personalized immune microenvironment with single-cell RNA sequencing and maximize the translational potential of in vitro cellular response to unify the identification of synergistic drug/small molecule combinations or small molecules that can be paired with immune checkpoint inhibitors to boost immunotherapy from a large collection of small molecules and drugs, and finally prioritize them for personalized clinical use based on bipartition graph optimization.ResultsWe apply comboSC to publicly available 119 single-cell transcriptome data from a comprehensive set of 119 tumor samples from 15 cancer types and validate the predicted drug combination with literature evidence, mining clinical trial data, perturbation of patient-derived cell line data, and finally in-vivo samples.ConclusionsOverall, comboSC provides a feasible and one-stop computational prototype and a proof-of-concept study to predict potential drug combinations for further experimental validation and clinical usage using the single-cell transcriptome, which will facilitate and accelerate personalized tumor treatment by reducing screening time from a large drug combination space and saving valuable treatment time for individual patients. A user-friendly web server of comboSC for both clinical and research users is available at www.combosc.top. The source code is also available on GitHub at https://github.com/bm2-lab/comboSC.
Keyword:
Single-cell RNA-seq
Immunotherapy
Combination therapy optimization
Bipartite graph
Computational pipeline
Web server
Precision medicine
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
11.2
论文数:
2.3K
被引数:
1.4W
机构
引用论文
The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells单细胞的假时间顺序揭示了细胞命运决定的动力学和调节剂.png)
NATURE BIOTECHNOLOGYOAAI
NATURE BIOTECHNOLOGYIF41.7
OAAI分享收藏A single-cell and spatially resolved atlas of human breast cancers人类乳腺癌的单细胞和空间分辨图谱NATURE GENETICSOAAI
NATURE GENETICSIF31.8
OAAI分享收藏Statin inhibits hypoxia-induced endothelin-1 via accelerated degradation of HIF-1 in vascular smooth muscle cellsCARDIOVASCULAR RESEARCH
OAAI
CARDIOVASCULAR RESEARCHIF13.3
OAAI分享收藏Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis乳腺肿瘤微环境的时间分布显示胶原蛋白XII是转移的驱动因素NATURE COMMUNICATIONSOAAI
NATURE COMMUNICATIONSIF15.7
OAAI分享收藏LINCS Data Portal 2.0: next generation access point for perturbation-response signaturesLINCS数据门户2.0: 扰动响应签名的下一代接入点NUCLEIC ACIDS RESEARCHOAAI
NUCLEIC ACIDS RESEARCHIF13.1
OAAI分享收藏
查看更多内容